From the SDPA Annual Summer Dermatology Conference 2018, held June 27 – July 1, 2018 in Seattle, Washington.
Topic: How I Manage Atopic Dermatitis in 2018
Faculty: Robert Sidbury, MD
Learning Objectives:
1. Discuss efficacy and safety data for new topical phosphodiesterase inhibitor for mild to moderate atopic dermatitis, crisaborole, and how it fits into the therapeutic armamentarium
2. Discuss efficacy and safety data for new systemic biologic medication for moderate to severe atopic dermatitis, dupilumab, and how it fits into the therapeutic armamentarium
3. Discuss pipeline of new atopic dermatitis therapies on the horizon